---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-016833"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2023-01-27T23:59:59+00:00"
generated_at: "2026-06-20T07:35:17.745694+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare Q4 net income $2.08B ($7.28 EPS); revenue $15.5B; new $3B buyback

## Summary
- Q4 revenue $15.50B (+2.9% YoY); net income $2.08B ($7.28 diluted EPS) incl $1.33B facility-sale gains.
- Adjusted EBITDA $3.18B vs $3.15B YoY; same-facility admissions +2.9%, ER visits +11.4%.
- FY2022 revenue $60.23B, net income $5.64B ($19.15 EPS); adjusted EBITDA $12.07B.
- Board authorized new $3B share repurchase program; declared quarterly dividend of $0.60/sh payable Mar 31.
- 2023 guidance: revenue $61.5-63.5B, EPS $16.40-17.60, capex ~$4.3B.

## SEC filing metadata
- accession: 0001193125-23-016833
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2023-01-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312523016833/0001193125-23-016833-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312523016833/d268135d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-016833
- JSON: https://secwatch.observer/filing/0001193125-23-016833.json
- Plain text: https://secwatch.observer/filing/0001193125-23-016833.txt

## Key facts
- Earnings Releases
  HCA Healthcare, Inc. reported fourth quarter ended December 31, 2022 results: revenue $15.497 billion, net income $2.081 billion, EPS $7.28 per diluted share. Guidance initiated.
  - Period: fourth quarter ended December 31, 2022
  - Revenue: $15.497 billion
  - Net income: $2.081 billion
  - EPS: $7.28 per diluted share
  - Guidance: initiated
  - Result: reported results
  source text: results for the fourth quarter ended December 31, 2022. Key fourth quarter metrics (all percentage changes compare 4Q 2022 to 4Q 2021 unless otherwise noted): ● Revenues totaled $15.497 billion ● Net income attributable to HCA Healthcare, Inc. totaled $2.081 billion, or $7.28 per diluted share ● Adjusted EBITDA totaled $3.179 billion ● Cash flows from operating
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312523016833/0001193125-23-016833-index.htm
- Earnings Releases
  HCA Healthcare, Inc. reported year ended December 31, 2022 results: revenue $60.233 billion, net income $5.643 billion, EPS $19.15 per diluted share. Guidance initiated.
  - Period: year ended December 31, 2022
  - Revenue: $60.233 billion
  - Net income: $5.643 billion
  - EPS: $19.15 per diluted share
  - Guidance: initiated
  - Result: reported results
  source text: Revenues for the year ended December 31, 2022 totaled $60.233 billion, compared to $58.752 billion in the same period of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312523016833/0001193125-23-016833-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.